CN-A reduced the expression of the oncogene N-myc, a neuroblastoma marker that has been reported to be expressed in retinoblastoma tumors and fetal retinas (but not adult retinas) [23], and to decrease during the differentiation of neuroblastoma [24] and retinoblastoma cell lines [25]. Here, MYCN is linked to retinoblastoma.